Related Experiment Video
Updated: Mar 14, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis
Rene Baudrand1, Nidhi Gupta2, Amanda E Garza2
1Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA Department of Endocrinology, School of Medicine, Pontificia Universidad Catolica De Chile, Santiago, Chile.
Background:
Overactivation of the aldosterone and mineralocorticoid receptor (MR) pathway is associated with hyperglycemia and dyslipidemia. Caveolin 1 (cav-1) is involved in glucose/lipid homeostasis and may modulate MR signaling. We investigated the interplay between cav-1 and aldosterone signaling in modulating insulin resistance and dyslipidemia in cav-1-null mice and humans with a prevalent variant in the CAV1 gene.
Methods And Results:
In mouse studies, cav-1 knockout mice exhibited higher levels of homeostatic model assessment of insulin resistance, cholesterol, and resistin and lower ratios of high- to low-density lipoprotein (all P<0.001 versus wild type). Moreover, cav-1 knockout mice displayed hypertriglyceridemia and higher mRNA levels for resistin, retinol binding protein 4, NADPH oxidase 4, and aldose reductase in liver and/or fat tissues. MR blockade with eplerenone significantly decreased glycemia (P<0.01), total cholesterol (P<0.05), resistin (P<0.05), and described enzymes, with no effect on insulin or triglycerides. In the human study, we analyzed the CAV1 gene polymorphism rs926198 in 556 white participants; 58% were minor allele carriers and displayed higher odds of insulin resistance (odds ratio 2.26 [95% CI 1.40-3.64]) and low high-density lipoprotein (odds ratio 1.54 [95% CI 1.01-3.37]). Aldosterone levels correlated with higher homeostatic model assessment of insulin resistance and resistin and lower high-density lipoprotein only in minor allele carriers. CAV1 gene expression quantitative trait loci data revealed lower cav-1 expression in adipose tissues by the rs926198 minor allele.
Conclusions:
Our findings in mice and humans suggested that decreased cav-1 expression may activate the effect of aldosterone/MR signaling on several pathways of glycemia, dyslipidemia, and resistin. In contrast, hyperinsulinemia and hypertriglyceridemia are likely mediated by MR-independent mechanisms. Future human studies will elucidate the clinical relevance of MR blockade in patients with genotype-mediated cav-1 deficiency.
Insights
Reduced caveolin 1 (cav-1) expression may worsen insulin resistance and dyslipidemia by enhancing aldosterone signaling. This study investigated the link between cav-1 and aldosterone in mice and humans, finding decreased cav-1 exacerbates these conditions.
Area of Science:
- Endocrinology
- Metabolic Syndrome
- Genetics
Background:
- Aldosterone and mineralocorticoid receptor (MR) pathway overactivation is linked to hyperglycemia and dyslipidemia.
- Caveolin 1 (cav-1) plays a role in glucose/lipid homeostasis and may influence MR signaling.
Purpose of the Study:
- To investigate the interplay between cav-1 and aldosterone signaling in insulin resistance and dyslipidemia.
- To examine these effects in both cav-1-null mice and humans with a common CAV1 gene variant.
Main Methods:
- Studied cav-1 knockout mice and analyzed the CAV1 gene polymorphism rs926198 in 556 human participants.
- Assessed insulin resistance, lipid profiles, resistin levels, and gene expression.
- Investigated the effects of MR blockade with eplerenone in mice.
Main Results:
- Cav-1 knockout mice showed increased insulin resistance, cholesterol, resistin, and hypertriglyceridemia.
- MR blockade in mice reduced glycemia, cholesterol, and resistin but not insulin or triglycerides.
- Human carriers of the minor CAV1 allele (rs926198) had higher odds of insulin resistance and low HDL, with aldosterone correlating with these markers.
Conclusions:
- Decreased cav-1 expression may potentiate aldosterone/MR signaling effects on glycemia, dyslipidemia, and resistin.
- Hyperinsulinemia and hypertriglyceridemia appear to be mediated by MR-independent pathways.
- Further research is needed to clarify the clinical relevance of MR blockade in individuals with genotype-mediated cav-1 deficiency.
More Related Videos
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
cAMP-dependent Protein Kinase Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Absorption Into the Small Intestine
GPCRs Regulate Adenylyl Cylase Activity
Insulin Secretory Vesicles